MyAverix Finance
TA · Healthcare
Evogene (EVGN)
Biotechnology
Evogene (EVGN) is listed on TA in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for EVGN
P/E ratio
25.00
Evogene (EVGN) — FAQ
What is EVGN's P/E ratio?
The price-to-earnings (P/E) ratio for Evogene (EVGN) is 25.00 (data as of 2026-05-24).
Does Evogene pay a dividend?
Dividend yield is not available in the current snapshot for Evogene (EVGN). Check the MyAverix Finance app for the latest dividend data.
What sector is Evogene in?
Evogene (EVGN) is classified in the Healthcare sector (Biotechnology industry).
What exchange is EVGN listed on?
EVGN is listed on TA.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.